Thomas G. Ricks - Jun 10, 2022 Form 4 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role: Director
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol: SNSE
Transactions as of: Jun 10, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/14/2022, 04:15 PM
Previous filing: Jun 8, 2022
Next filing: Jul 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SNSE	Common Stock	Award	$0	+4.47K		$0.00	4.47K	Jun 10, 2022	Direct	F1
holding	SNSE	Common Stock						335K	Jun 10, 2022	By Ricks Family Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SNSE	Stock Option (Right to Buy)	Award	$0	+14.6K		$0.00	14.6K	Jun 10, 2022	Common Stock	14.6K	$2.05	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
F2	These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and, accordingly, may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.
F3	The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.